Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement

Am J Cardiol. 2000 Mar 1;85(5):664-5, A11. doi: 10.1016/s0002-9149(99)00832-2.

Abstract

Survival of > or =5 years was seen in 8 of 153 patients (5%) with primary systemic amyloidosis and cardiac involvement. All patients with survival of >5 years received chemotherapy and all but 1 had an objective chemotherapeutic response.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Amyloidosis / mortality*
  • Amyloidosis / pathology
  • Biopsy
  • Cardiomyopathies / mortality*
  • Cardiomyopathies / pathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardium / pathology
  • Survival Rate
  • Time Factors